Inhibition of the Wnt signaling pathway is an appealing anti-cancer strategy but most attractive targets are involved in protei -protei i tera tio s PPIs). Inhibition of such intracellular PPIs is extremely challenging since involved proteins are not accessible for biologics and often lack defined binding pockets complicating the use of small molecules. In principle, peptide-derived modalities hold the potential to bind flat protein surfaces as they are found in PPIs. However, the implementation of robust cellular uptake is complicated which hampers their usefulness. Herein, we investigate the cell penetration properties of a stapled peptide targeti g the i tera tio et ee β-catenin and TCF/LEF transcription factors which are crucially involved in Wnt signaling. Based on lessons learned from cell-penetrating peptides (CPPs), we design a peptidomimetic with excellent cellular uptake hile preser i g its affi it for β-catenin. In cell-based assays, this inhibitor shows activity in the low micromolar range exceeding the potency of currently available β-catenin targeting agents.
INTRODUCTION
Modified peptides and peptidomimetics represent promising scaffolds for the design of inhibitors of very challenging biological targets. In particular, this involves the inhibition of protein-protein interactions (PPIs) which, due to the absence of addressable pockets, often prove to be reluctant to a targeting by small molecules. Peptides show a propensity to bind flat protein surfaces which are often found in PPI interfaces (Pelay-Gimeno et al. 2015; Qvit et al. 2016) . However, most peptides are incapable of passing the cell membrane which limits their usefulness for the inhibition of intracellular targets. Notably, there are exceptions such as cell-penetrating peptides (CPP) which either contain mainly positively charged amino acids (polycationic CPPs, e.g. R 8 and Tat) or an alternating pattern of charged and hydrophobic side chains (amphipathic CPPs) (Ziegler 2008) . Primary amphipathic peptides are composed of an isolated hydrophobic as well as hydrophilic stretch (e.g. Pep-1). Pep-1 for example consists of a nuclear localization sequence (NLS) contributing positive charges and a hydrophobic tryptophan-rich motif (Morris et al. 2007 ). Secondary amphipathic peptides on the other hand (e.g. Penetratin) show their amphipathic character only upon adaptio of a defi ed se o dar stru ture e.g. α-helix) which places hydrophobic and polar residues on opposite sides of the molecule (Deshayes et al. 2011; Eiriksdottir et al. 2010) .
Various factors are postulated to support cell surface engagement and penetration of peptides. In general, interactions between positively charged amino acids in CPPs and negatively charged components of the glycocalyx represent the first step towards cellular internalization . In this respect, arginine proved to be particularly useful (Gasparini et al. 2015; Wender et al. 2008; Wexselblatt et al. 2014) . However, charge alone is often insufficient to ensure efficient uptake since charge distribution, secondary structure and hydrophobicity also play important roles. For example, it was shown that macrocyclization of CPPs can improve cellular uptake (Chu et al. 2015; Nischan et al. 2015; Qian et al. 2016; Upadhyaya et al. 2015) . Hydrophobicity is integral to amphipathic CPPs and crucial for bilayer insertion and penetration, as hydrophobic amino acids (e.g. tryptophan) interact with the core of membranes (Gallivan et al. 1999; Persson et al. 1998; Regberg et al. 2014; Rydberg et al. 2012) . Along those lines, lipidation can also favor the uptake of polar and amphipathic peptides (Lee et al. 2010; Mae et al. 2009; Nelson et al. 2007; Oh et al. 2014) . It is important to note that the polar backbone largely contributes to the low cellular uptake of peptides. For that reason, several approaches were pursued to shield backbone amides. That involves N-methylation and the stabilization of certain peptide secondary structures that burry the backbone (Chatterjee et al. 2008; Chatterjee et al. 2013; Pelay-Gimeno et al. 2015) . A particularly successful strateg represe ts the sta ilizatio of α-helices (Azzarito et al. 2013) , with hydrocarbon peptide stapling being among the most widely used approaches (Bird et al. 2016; Cromm et al. 2015) . Overall, the structural diversity of CPPs complicates the identification of stringent rules that would allow a robust implementation of cell permeability (Brock 2014) . This is a tremendous limitation for the design of peptide-derived inhibitors of intracellular proteins.
One particularly challenging intracellular target is β-catenin which regulates the Wnt signaling pathway via numerous PPIs. Wnt signaling governs substantial aspects of cell proliferation and differentiation and is involved in the onset and progression of numerous types of cancer. In colorectal cancer for example, hyperactive Wnt signaling occurs in more than 80% of all cases (Chiurillo 2015; Muller et al. 2016) . In most adult cells, the Wnt pathway is inactive and β-catenin is constantly degraded by the so-called destruction complex composed of the proteins Adenomatous polyposis coli (APC), Axin, casein kinase 1 (CK1α) and glycogen synthase kinase 3 (GSK3), among others. The destruction complex triggers phosphorylation and subsequent degradation of β-catenin. In healthy cells, activation of Wnt signaling is triggered by diffusible extracellular Wnt proteins which bind to the transmembrane receptor Frizzled (FZD) forming a complex with the low-density lipoprotein receptor-related protein 5/6 (LRP5/6). This leads to the recruitment of Dishevelled (Dvl) and Axin thereby blocking degradation of β-catenin. As a result, β-catenin accumulates and translocates into the nucleus where it triggers the formation of the transactivation complex leading to the transcription of Wnt target genes (Clevers et al. 2012) . In an oncogenic context, hyperactivation of Wnt signaling is often triggered by a reduction of destruction complex activity, e.g. via mutations in APC, Axin or β-catenin itself, resulting in high levels of β-catenin (Polakis 2012).
Approaches to inhibit Wnt signaling mainly involve the targeting of upstream pathway components:
Transmembrane receptors have been inhibited with antibodies and peptidomimetics (Gurney et al. 2012; Jenei et al. 2009; Newnham et al. 2015; Safholm et al. 2008) . Small molecules and macrocycles have been used to inhibit the segregation and maturation of Wnt ligands (Chen et al. 2009; Liu et al. 2013; Madan et al. 2016; Proffitt et al. 2013; Xu et al. 2017) and to target enzymes crucial for the function of the destruction complex (Chen et al. 2009; Huang et al. 2009; James et al. 2012; Thorne et al. 2010; Waaler et al. 2012 ).
Since oncogenic mutations often occur in components of the destruction complex which is located in the center of the Wnt pathway, the usefulness of strategies targeting upstream components is limited. Inhibition of the transactivation complex (downstream in the pathway) would be insensitive to such mutations and is therefore considered an appealing anti-cancer strategy (Bertoldo et al. 2016; Emami et al. 2004; Gonsalves et al. 2011) . Two stapled peptides have been reported to disrupt intracellular PPIs that involve β-catenin representing a first proof-of-concept (Grossmann et al. 2012; Takada et al. 2012) . One of them is StAx (originally named StAx-35R) which targets the interaction between β-catenin and TCF/LEF transcription factors (Grossmann et al. 2012 ) but suffers from relatively low bioactivity presumably due to low cellular uptake. Herein we describe an integrative strategy to convey robust cellular uptake considering lessons learned from CPPs combined with the utilization of additional hydrophobic and positively charged modalities. This strategy yields a molecule with excellent cellular uptake showing high selectivity for β-catenin and very potent inhibition of proliferation and migration in intestinal cell-based assays.
RESULTS

Comparison of cellular uptake
Aiming for the installation of robust cell penetration of stapled peptide StAx, uptake properties of known cell penetrators were compared using five CPPs and one additional stapled peptide (SAHM1, Notch inhibitor (Moellering et al. 2009)) . Among the CPPs, polycationic (Tat 49-57, R 8 ) as well as primary (Pep-1) and secondary (Penetratin) amphipathic sequences were selected ( Figure 1A ). For the assessment of cellular uptake, we used fluorescently labeled versions (f-, fluorescein) of these peptides. It is important to note that the quantitation of uptake is challenging as all established methods suffer from limitations. We decided to avoid techniques that require the fixation of cells as fixation tends to generate false positive results (Richard et al. 2003) , and chose a combination of fluorescence confocal microscopy and flow cytometry both employing live cells. Live cell confocal microscopy allows the subcellular localization of peptides but is not quantitative, while flow cytometry is quantitative but does not provide spatial information. Table S2 ). Net charge of peptides is given (calculated with property calculator by Innovagen AB). For flow cytometry experiments, HeLa cells were incubated with labeled peptides (5 µM, 90 min), then stringently washed and treated with protease to remove cell-surface bound peptides. The mean fluorescence intensity (mFI) of analyzed cells reveals for all peptides higher uptake than for the fluorescent label (fluorescein) alone ( Figure 1B ). Within this panel, primary amphipathic peptide Pep-1 and stapled peptide SAHM1 convey in highest fluorescence intensities, while polycationic peptides (Tat , R 8 ) and secondary amphipathic peptide Penetratin show considerably lower uptake. Interestingly, the uptake of StAx is also in this range and about 7-fold lower than the one of Pep-1 and SAHM1. Using confocal microscopy, we examined the subcellular localization revealing for all peptides (though to a varying extent) cytosolic and nuclear distribution as well as accumulation in intracellular vesicular structures presumably endosomes (Brock 2014) (Figure 1C ). SAHM1, Pep-1 and R 8 exhibit a comparably high cytosolic fraction while StAx and Penetratin show predominantly vesicular localization. Taken together, stapled peptide SAHM1 and CPP Pep-1 combine cytosolic distribution (microscopy) with high overall uptake (flow cytometry). StAx is only moderately internalized and shows low cytosolic distribution which is similar to the behavior of Tat and Penetratin. Considering StA ' positive net charge (+5.1), stabilized helical conformation and hydrophobic character, it already possesses fundamental features for uptake explaining its basic cell permeability. To increase cellular uptake and ensure robust bioactivity, we applied a strategy that on the one hand aims at fine tuning of core sequence hydrophobicity, and on the other hand explores a variety of Nterminal modifications to introduce additional hydrophobic or polar groups.
Variation of Stapled Peptide StAx
StAx ( Figure 2A ) was previously optimized for high target affinity and to incorporate the maximum number of arginines (R) that were compatible with target binding. As a result, there was little potential for additional variations to be made to the core peptide sequence (Figure 2A ). Knowing that the six arginine residues in StA do ot sig ifi a tl o tri ute to β-catenin binding, we considered the modification of these sites. Since the positively charged guanidinium group is crucial for cell penetration, we focused on the modulation of its alkyl chain aiming at increasing its hydrophobic character, a strategy that has already proven useful for the improvement of CPPs (Wender et al. 2000) . For that reason, arginine derivatives with altered linker structures namely homo-arginine (hR, longer alkyl linker) and 4-guanidino-phenylalanine (pR, aromatic linker) were incorporated instead of the natural amino acid ( Figure 2B ). In the two new resulting peptides, all arginines were replaced either by hR (StAx-h) or by pR (StAx-p). In fluorescence polarization (FP) assays, we verified that peptides f-StAx-p and f-StAx-h exhibit an affinity for recombinant full length β-catenin (K d = 66 and 123 nM, respectively) that is in the range of the original StAx peptide (K d = 108 nM, Figure S1 ). Based on these three core sequences, we selected a diverse set of N-terminal modifications ( Figure 2C ).
Attachment of different hydrophobic moieties including acetylation (Ac-), capronylation (C 6 ) and palmitoylation (C 16 -) stepwise increases hydrophobicity and presumably affinities for membranes. In addition, we investigated hydrophilic modalities involving the free N-terminus (H 2 N-) and Spermine (sp-) as well as the nuclear localization sequence (NLS-) of SV40 large T-antigen. This NLS peptide sequence contains four lysines and one arginine ( Figure 2C ) and was previously used to improve both cellular uptake and nuclear localization (Ragin et al. 2002) . The latter is an aspect which may also support biological activity of StAx peptides since the target protein complex is enriched in the nucleus (Cadigan et al. 2012 ).
The resulting 21 peptides (including fluorescently labeled versions) were synthesized and tested regarding their potential to inhibit canonical Wnt signaling in a cell-based assay. For that purpose, 293T cells were transfected with two vectors: One with 7 tandem repeats of a TCF/LEF response element (including minimum promoter) upstream of firefly luciferase (TOPflash), and another one with Renilla luciferase for normalization (Lanier et al. 2012) . Wnt signaling was activated in an autocrine and paracrine fashion by cotransfection with a third vector expressing the Wnt3A ligand. Cells were incubated with varying peptide concentrations (0.1-10 µM) and luciferase activity was measured after 22 h. Corresponding half maximal inhibitory concentrations (IC 50 ) were determined. For assay validation, we tested the known Wnt inhibitor XAV939 acting upstream in the signaling pathway which shows inhibition in the expected activity range (IC 50 = 0.07 µM, Figure S2 ). Our peptide panel shows diverse inhibitory effects ( Figure 2D ) but importantly no general toxicity within the tested dose range (based on Renilla luciferase). Among the three core sequences, StAx-h harboring six homo-arginine residues shows highest Wnt pathway inhibition. Within the StAx-h series, small and/or hydrophilic modifications result in highest activities with H 2 N-and NLS-being the most active ones (IC 50 = 1.4 µM).
StAx-h peptides are efficient cell penetrators
Knowing that the three core sequences (StAx, StAx-p, StAx-h sho si ilar affi it for β-catenin ( Figure S1 ), we suspected that differences in inhibitory activity originate from differences in cellular uptake and distribution. To test this hypothesis, cell penetration was investigated by flow cytometry and microscopy employing fluorescently labeled versions of the three core peptides (f-StAx, f-StAx-p, f-StAx-h). In addition, fluorescently labeled NLS-modified StAx-h (f-NLS-StAx-h) was included as it showed highest activity in the reporter gene assay (together with H 2 N-StAx-h). Flow cytometry-based readout of cellular uptake was performed using a dilution series of peptides (0.1-5 µM, 90 min, Figure 3A ). Overall, uptake increases with peptide concentration (though to a varying extent) with all variants showing improved penetration when compared to the original StAx peptide (black). Interestingly, f-NLS-StAx-h exhibits the largest increase (7-fold at 5 µM) with respect to StAx placing it in the range of the best CPPs (mFI at 5 µM: 17.0 for f-NLS-StAx-h, 16.4
for Pep-1, Figure 1B ). Subsequently, life cell confocal microscopy was performed (5 µM, 90 min, Figure 3B ) to investigate the subcellular localization of all four peptides. Peptide f-StAx-p is predominantly membrane associated ( Figure 3B ) presumably do the strong hydrophobic character of the aromatic moiety in pR. In contrast, the two StAx-h derivatives show considerable cytosolic distribution which is particularly pronounced for f-NLS-StAx-h ( Figure 3B ). 
StAx-h binds β-catenin and inhibits Wnt target gene expression
Taken together, Wnt reporter activity ( Figure 2D ) and cell permeability ( Figure 3 ) indicate that core sequence StAx-h holds the highest potential for efficient inhibition of Wnt signaling. Before investigating StAx-h pote i detail, e ai ed for the alidatio of its i di g to β-catenin in a cellular context. For that purpose, pull-down experiments were performed using a biotinylated version of StAx-h (b-StAx-h). The peptide was immobilized on Streptavidin beads and incubated with the lysate of DLD-1 cells, a colon cancer cell line ith ele ated β-catenin levels. After stringent washing, bound proteins were subjected to tryptic digestion and fragments analyzed by HPLC-coupled high-resolution mass spectrometry. Identified proteins were plotted in accordance to their enrichment and statistical relevance compared to pull-down with beads only. The resulting volcano plot ( Figure 4A ) shows 37 proteins that are significantly enriched ith β-catenin being one of the highest scoring ones (orange, Figure 4A ). Most strikingly, among the remaining 36 proteins, 17 are proposed o po e ts of β-catenin containing complexes (blue, Figure 4A , for complete list see Table   S3 ) supporting selective binding of StAx-h to β-catenin. Most of these potential complex partners are either involved in transcriptional activator complexes (e.g. RUVBL1 and RUVBL2) or cell-cell adhesion junctions (e.g.
α-catenin and E-cadherin).
Having verified StAx-h as β-catenin binder, we investigated its effects on the expression of Wnt target genes using mouse-derived small intestinal crypt organoids expressing a doxycycline(dox)-inducible and stable form of β-catenin (activated β-catenin) (Dale et al. 2015; Jarde et al. 2013) . Importantly, removal of dox (-dox, Figure 4B ) results i loss of a ti ated β-catenin thereby reducing the mRNA level of Wnt target genes (e.g. Axin2, Myc, Ascl2, Tiam1) and increasing levels of differentiation marker Car4. Notably, treatment
with H 2 N-StAx-h ( Figure S3 ) or NLS-StAx-h ( Figure 4B ) results in gene expression changes consistent with inhibition of Wnt signaling following loss of activated β-catenin resulting from doxycycline removal (-dox, Figure 4B ). For NLS-StAx-h, this effect is observed as early as 2 h after initiation of treatment and plateaus after ca. 6 h ith RNA le els i the ra ge of the o trol sa ple la ki g a ti ated β-catenin expression. As an additional control, StAx-h-derived peptide StCo (for sequence see Table S2 ) was designed that shows greatl di i ished affi it for β-catenin (K d ~ 10 µM, Figure S1 ) due to the substitution of three amino acids dire tl i ol ed i β-catenin binding. Importantly, the NLS-modified version of this peptide (NLS-StCo) does not alter the level of investigated Wnt-responsive target genes ( Figure 4B ). Table   S2 ). mRNA level of Wnt target genes (Myc, Ascl2, Tiam1 or Axin2), and of differentiation marker Car4 were quantified. Gene expression changes as a result of removal of do for the last h -do are shown on the left. Experiments were performed as three independent biological replicates, each with three technical replicates. Values in all bar graphics depict mean values a d error ars represe t σ. *p < 0.05, ns = not significant.
NLS-StAx-h Inhibits Proliferation and Migration of Colorectal Cancer Cells
Inhibition of Wnt signaling reduces growth of Wnt-dependent cancer cell lines but has no effect on cells that grow independent of Wnt signaling. To test activity and specificity of StAx-h peptides, cancer cell lines originating from different human tissues were screened for their sensitivity towards inhibitor treatment. This involves Wnt-addicted colon cancer cell lines DLD-1 and SW-480 in which the Wnt-pathway is activated via truncations of the destruction complex component APC. In addition, we chose cell lines that are reported to be Wnt-independent: U87 glioblastoma cells, MCF-7 breast cancer cells and U2OS osteosarcoma cells (Forbes et al. 2015) . Viability read-out was performed via quantitation of cellular ATP levels. Compared to previous studies, inhibitors (c = 10 µM) were tested under stringent conditions using normal serum concentration (rather than starving conditions) (Huang et al. 2009 ) and a relatively short incubation time of 72 h (compared to 5-6 d) (Chen et al. 2009; Fujii et al. 2007; Grossmann et al. 2012) . Under these conditions, Figure 5A ). Control peptide NLS-StCo, lacking affinity for β-catenin, does not have an effect on viability. As expected, none of the StAx-derived peptides inhibits growth of Wnt-independent cell lines (U87, U2OS and MCF7, Figure 5A ). Interestingly, XAV939 shows some effect on the viability of MFC7 cells (48 % inhibition) indicating some activity that is independent from inhibition of Wnt signaling.
Having studied the cellular uptake of fluorescently labeled StAx-derivatives in detail, we also tested their effect on viability ( Figure S4 ). In line with the reporter gene assay and its relatively low cellular uptake,
f-StAx-h shows very low activity on Wnt-dependent SW-480 cells. For f-NLS-StAx-h, we observe activity in the range of the non-labeled version indicating comparable cellular uptake. Interestingly, both fluorescently labeled peptides (f-StAx-h and f-NLS-StAx-h) cause ca. 20% reduction of viability for Wnt-independent MFC-7 cells ( Figure S4 ) indicating non-specific toxicity caused by the fluorescein label. Notably, the most active peptide (NLS-StAx-h) harbors a nuclear localization signal which apparently does not result in nuclear accumulation ( Figure 3B ). For that reason, we were interested if its high cellular activity is predominantly caused by high cellular uptake due to the five positively charged NLS side chains. For that purpose, a charge analog harboring five N-terminal lysine residues instead of the NLS (KKKKK-StAx-h) was designed. And indeed, KKKKK-StAx-h reduces the viability of Wnt-addicted SW-480 similar to NLS-StAx-h while not affecting Wnt-independent MCF-7 cells. In line with this observation, the overall cellular uptake of f-KKKKK-StAx-h is only slightly lower than that of f-NLS-StAx-h (mFI at 5 µM: 13.9 vs. 17.0, Figure S5 ) indicating that the high cellular activity of the NLS-modified version is mainly triggered by increased cellular uptake supported by positive charges within the NLS. The active Wnt pathway not only supports cell proliferation, but also cell migration which crucially contributes to cancer metastasis (Iskit et al. 2015; Li et al. 2011; Sack et al. 2011) . Thus, most active peptide introduction of a sterile wound (blue, Figure 5B ), cells were treated either with DMSO or with one of the peptides for 24 h. In absence of peptide (DMSO), the original wound was already closed by 69 % after 24 h, while NLS-StAx-h treatment resulted in dose-dependent inhibition of this process (wound closure: 52 % at 5 µM, and 24 % at 10 µM, Figure 5B and C). As expected, NLS-StCo (10 µM) shows no inhibitory effect. This robust inhibition of cell migration, was confirmed by time-dependent measurements ( Figure 5D ) revealing significant inhibition of wound-closure as early as 5 h after initiation of treatment. As an additional control, we performed the wound-closure assay with Wnt-independent MCF-7 cells. Importantly, these cells were not affected by NLS-StAx-h treatment ( Figure S6 ). Together with the inactivity of control peptide NLS-StCo, this indicates that indeed Wnt-inhibition is responsible for observed effects on the migration of DLD-1 cells.
DISCUSSION
Previously we reported a stapled peptide (StAx) that targets β-catenin, the central hub in canonical Wntsignaling, but its activity suffers from low cellular uptake. Even though there is some rational, it is not possible to design highly cell permeable and bioactive stapled peptides from scratch (Bird et al. 2016; Chu et al. 2015; Cromm et al. 2016) . It is known that some features appear to be necessary (but not sufficient) for efficient uptake of positively charged peptides: (a) A certain degree of hydrophobicity, and (b) A spatially separated hydrophobic and cationic stretch. Presumably, this is due to a two-step uptake mechanism that initially involves interaction of cationic peptide groups with negatively charged membrane components which is followed by insertion of hydrophobic residues into the membrane core.
To evaluate cell permeability of StAx, we compared its cellular uptake and localization with known CPPs (5 µM, 90 min, HeLa cells). Interestingly, StAx uptake is in the range of first generation CPPs such as Tat but about 7-times lower than best performing peptides Pep-1 and SAHM1. StAx already has a number of hydrophobic and positively charged amino acids, however, they are spatially not separated. Since there is only little room for a variation of the StAx core sequence, we decided to pursue a strategy that considers minor sequence alterations (derivatization of existing arginines) and a set of hydrophobic and polar Nterminal modifications (including an NLS). At this point, it was not clear whether uptake would be supported by additional cationic or hydrophobic groups. After validating that arginine derivatization does not interfere ith β-catenin binding, a small library consisting of 21 modified peptides was synthesized and tested regarding their activity in a Wnt-dependent reporter gene assay. This assay showed that polar N-terminal modifications in combination with a slightly more hydrophobic core sequence (homo-arginine instead of arginine) provide most active peptides. While activity trends observed for the reporter gene assay are in line with growth inhibition, the dynamic range in the reporter gene assay is smaller. This behavior can be due to the non-physiological concentration and activity of the promotor used in the reporter gene assay, and it highlights the importance of more relevant secondary cell-based assays for hit validation. Analysis of cell permeability revealed that in particular the analogue with an N-terminal NLS sequence (NLS-StAx-h) shows very high cellular uptake and cytosolic distribution comparable to best cell penetrators Pep-1 and SAHM1.
Interestingly, a charge analog bearing five lysine residues instead of the NLS shows similar cellular uptake indicating that the basic character of the NLS is of central importance.
Having an active a d ell per ea le peptide a aila le, e ere i terested if the peptide i deed targets β-catenin in a cellular context. To address this question, pull-down experiments were performed using a biotinylated StAx-h peptide and analyzed with high-resolution MS. In this assay, β-catenin and some of its k o i di g part ers ere sig ifi a tl e ri hed erif i g β-catenin binding. Notably, we did not identify any of the LEF/TCF transcription factors which is expected since they compete with StAx-h for β-catenin binding. Analysis of changes in the transcription of Wnt-target genes in mouse-derived small intestinal crypts unambiguously shows inhibition of Wnt signaling after treatment with StAx-h. Importantly, an NLS-StAx-h derived control peptide (NLS-StCo) does not affect mRNA level of these genes.
In a number of cancer cells types, expression of Wnt-target genes is essential for cell proliferation and migration which are crucial for the oncogenicity of these cells. Consequently, selective inhibition of Wntsignaling is considered an appealing anti-cancer strategy. In this respect, it is important to note that oncogenic mutations that lead to hyperactive Wnt-signaling are often found downstream (right Figure 6) , i.e. To investigate the potency and specificity of NLS-StAx-h, we tested its impact on the viability of Wntdependent and -independent cell lines. Applying stringent assay conditions (high serum concentration and relatively short incubation times), we observed inhibition of proliferation (80% inhibition after 72 h) and migration (2.8-fold reduced wound-closure after 24 h) only for Wnt-dependent cell lines. Importantly, activity of NLS-StAx-h exceeds that of known Wnt inhibitor XAV939 which stabilizes a component of the destruction complex and does not show inhibition of cell proliferation under our stringent conditions. The same holds true for starting peptide StAx which highlights the importance of robust cellular uptake for high activity. Interestingly, published small molecule inhibitors of downstream Wnt-signaling are required to be applied at higher concentrations (iCRT3: 75 µM, ICG-001: 25µM vs. NLS-StAx-h: 10 µM) to interfere with cell proliferation (Emami et al. 2004; Gonsalves et al. 2011) . Given the inherent difficulties associated with peptide uptake, this is highly remarkable and highlights the significance of our optimization strategy as well as the importance of NLS-StAx-h for the future investigation of approaches that target the Wnt transactivation complex.
SIGNIFICANCE
The development of highly cell permeable and bioactive peptides is extremely challenging and represents the bottleneck for an application of peptide-derived molecules. The strategy reported herein allowed the implementation of robust cell permeability using a stapled peptide with low cellular uptake as starting point.
Importantly, this approach should be applicable to a multitude of peptide-derived inhibitors that suffer from low uptake. Herein described stapled peptide NLS-StAx-h inhibits oncogenic Wnt signaling which is a driver in numerous types of cancer, in particular in colorectal cancer (CRC). CRC is the third most common cancer in men and the second most common cancer in women. The overall survival rate is as low as 8. 131605). We thank S. Gentz, K. Kuhr and F. Müller for technical assistance with peptide synthesis, highresolution mass spectrometry and pull-down assays, respectively.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Bacterial Strains
For expression of human full-le gth β-catenin Escherichia coli (E. coli) strain BL21-GOLD(DE3) was used and cultured in TB medium.
Cell Lines
The cell lines SW-480 and 293T were obtained from Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ) and the DLD-1 cell lines was purchased from the American Type Culture Collection (ATCC). HeLa, U87, MCF-7 and U2OS cell lines were kindly provided by Max Planck Institute of Molecular Physiology, Dortmund, Germany. Hek293T, HeLa, U87, MCF-7, U2OS were cultured in DMEM supplemented with 10% fetal calf serum, stable L-glutamine and 1x non-essential amino acids). DLD-1 and SW-480 were maintained in RPMI-1640 supplemented with 10% fetal calf serum and L-glutamine. Cultures were maintained at 37 °C in a humidified atmosphere of 5% CO2.
Mice
The Tet-O-β-catenin line mice had both the Tet-O-β-catenin allele and the ROSA26-M2-rtTA allele and were a mixed SV129 x C57Bl/6 background (Jarde et al. 2013 ). The small intestinal organoids used for the assays were obtained from a 4-o th old ale. The olo as red a d ai tai ed i o plia e ith the UK's Animal (Scientific Procedures) Act under project license 30/3279 in filter top cages in a specific pathogen free facility under 12 h light/12 h dark conditions. Water and food were provided ad libitum.
METHOD DETAILS Peptide Synthesis
Peptides were synthesized following standard Fmoc-protocols for solid-phase peptide synthesis (Kim et al. 2011 ). Abbreviations for used chemicals can be found in Table S1 . Peptide synthesis was performed on Rink amide NovaSyn®TGR (Merck) or ChemMatrix® resin (Sigma-Aldrich). Amino acids were dissolved in DMF including 0.5 M OxymaPure® and coupled twice or three times. For coupling, amino acids were mixed with 3.9 eq of HCTU and 8 eq of DIPEA in DMF and added to the resin for 40 min. After amino acid coupling, the remaining free amino groups were blocked with NMP/acetic anhydride/DIPEA (10/1/1) for 2 min. Fmocdeprotection was performed with 25 % piperidine in NMP for 10 min.
Crosslinking of unnatural olefinic amino acids (Okeanos Tech) was performed by ring closing metathesis (RCM). The dried resin was swollen in DCE for 30 min. A solution of Grubbs 1 st generation catalyst (4 g• L -1 ) in DCE was added to the resin and reacted for 1 h at room temperature. During reaction, nitrogen was bubbled through the mixture. The procedure was repeated five times and the resin was washed in a DMSO/DCM (1/1) solution for 10 min followed by a washing step in DCM.
To obtain a free N-terminus, peptides were deprotected with 25 % piperidine in NMP for 10 min. For acetylation, the last Fmoc-protecting group was removed and the free N-terminus was reacted twice with capping solution. Lipid and spermine modification were obtained through coupling of 4 eq of hexanoic acid, hexadecanoic acid or FBBSuc-OH using 3.9 eq PyBOP and 8 eq DIPEA. Fmoc-O2Oc-OH was coupled as a spacer to peptides subjected to FITC or NLS modification. FITC-labelling was performed twice with a 4-fold excess of FITC and 8 eq. DIPEA in NMP for 1 h. NLS was coupled according to the general SPPS protocol.
Before biotinylation, Fmoc-NH-PEG(5)-COOH was introduced N-terminally using 3.9 eq PyBOP and 8 eq DIPEA. D-Biotin was coupled twice using PyBOP and DIPEA.
Peptides were cleaved from the resin with TFA/H 2 O/TIPS (95/2.5/2.5) for 4 h and precipitated with diethyl ether at -20°C. Semi preparative HPLC was carried out on a LC-8A system (Shimadzu) using a Nucleodur C18 reverse-phase column (10 x 125 mm, particle size 5 µm, Macherey-Nagel; solvent A: water + 0.1 % TFA; solvent B: acetonitrile + 0.1 % TFA; flow rate: 6 L• i -1 ). Products were characterized on an analytical 1260
Infinity HPLC/ESI system (Agilent Technologies) equipped with a Zorbax C18 reverse-phase column (4.6 x 150 mm, particle size 5 µm, Agilent Technologies; solvent A: water + 0.1 % TFA; solvent B: acetonitrile + 0.1 % TFA; flow rate: 1 L• i -1 ). High-resolution mass spectra were recorded on a QLT Orbitrap mass spectrometer coupled to an Accela HPLC-System (HPLC column: Hypersyl GOLD, 50 mm x 1 mm particle size 1.9 µm, ionization method: Electrospray Ionization). Analytical data are shown in Supporting Table S2 .
According to Lambert-Beer law, yields were quantified by UV absorbance at 280 nm with an extinction coefficient of 11,000 M -1
•cm -1 (StAx) or 5,500 M -1
•cm -1 (StCo). FITC-labeled peptides were measured at 495 nm in 100 mM sodium phosphate buffer (pH 8.5) and calculated with an extinction coefficient of 77.000 M -1
•cm -1 .
β-catenin Expression and Purification
E. coli BL21-Gold(DE3) cells (Agilent Technologies) were transformed with a modified pET-28a(+) plasmid engineered to harbour a C-terminal hexahistidine-tag and PreScission cleavage site after the full-le gth β-catenin gene. The gene coding for the full-le gth β-catenin protein is based on Genbank entry NM_001904.3.
The fragment was obtained through gene synthesis (Integrated DNA Technologies). TB medium was inoculated with an overnight culture and incubated at 37° C until it reached an optical density of 1 at a wavelength of 600 nm. Protein expression was induced with 0.4 mM IPTG and incubated overnight at 18 °C.
The harvested cell pellet was resuspended in a lysis buffer containing 50 mM Tris pH8.0, 300 mM NaCl, 1 mM After 90 min treatment, cells were washed three times in warm PBS to remove excess peptide from the cell surface and left in pre-warmed imaging medium (PAN Biotech). Cells were immediately analyzed under a LSM510 meta confocal microscope (Zeiss) in a pre-warmed incubation chamber (37°C). By scanning through the z-planes of each cell, the outer plasma membrane borders were determined. Images were taken between the plasma membrane z-planes to obtain signals from internalized peptides and to minimize artificial signals from cell surface adhered peptides. Fluorescence was excited using a 488 nm argon laser (filter:505-540 BP). The distribution of FITC-labeled peptides was analyzed using a 63x Plan-Apochromat oil objective (Zeiss).
Dual Luciferase Reporter Gene Assay
Inhibitory potency of StAx peptides was tested with 293T cells in a 96-ell for at W t a/β-catenin luciferase reporter gene assay (Lanier et al. 2012 ). HEK293T cells were cultured in DMEM supplemented with 10 % FCS at 37 °C in 5 % CO 2 . For transient transfection, Lipofectamine®2000 (Thermo Fisher) and the appropriated plasmids were pre-incubated in Opti-MEM® medium for 15 min at room temperature. To cover a 96-well plate, 3x10 6 cells were transiently transfected with Wnt3A-expressing vector for pathway activation, together with the commercially available Super(8x)TOPflash reporter vector harboring a (7×)TCFfirefly luciferase response element and the TK-driven Renilla luciferase co-reporter vector, as an internal transfection control to normalize the luminescence, and again incubated at 37 °C in 5 % CO 2 . After 8 h, cells were harvested and counted. 25,000 transfected cells were seeded in 110 µL Media per well. Cells were allowed to adhere for 1 h. Cells were treated either with 10 µL of peptide solutions in different concentrations (final concentration 10, 5, 2.5, 1, 0.5, 0.25, 0.1 µM with 0.5 % DMSO), untreated and DMSO (0.5 %)-treated negative vehicle controls. After 22 h incubation, the medium was carefully aspirated.
A ordi g to the a ufa turer's proto ol, ells ere the l sed i l sis uffer follo ed the additio of luciferase substrates from the Dual Glo®Luciferase Assay System (Promega). Figure S2 ), non-linear regression analysis (four parameters, variable slope) was performed.
Pull-Down Assay
10 cm dishes from adherent DLD-1 cells (70-80% confluency) were lysed in 200 µL lysis buffer (20 mM HEPES pH 7.5, 10 mM KCl, 1 mM MgCl 2 , 1 mM Na 2 EDTA, 1 M EGTA, a d Halt™ Protease I hi itor Co ktail (ThermoFisher Scientific) by four freeze-thaw cycles in liquid nitrogen, followed by sonication. Cell debris was removed by centrifugation for 20 min, 10,000 g, 4 °C, and protein concentration of the supernatant was measured using Bradford-Reagent (Serva). The lysate was diluted in binding buffer (50 mM TRIS pH 8.0, 300 mM NaCl) to 1 mg/mL. Dynabeads® M-280 Streptavidin (ThermoFisher Scientific) with a loading capacity of 200 p ol• g -1 were saturated with biotinylated b-StAx-h peptide for 1 h at room temperature on a rotating wheel. After washing three times in binding buffer, the beads were incubated with 1 mL cell lysate for 3 h at 4 °C on a rotating wheel. As a background control, Streptavidin beads alone were used. After washing the samples three times in binding buffer, samples were subjected to quantitative mass spectrometry.
Mass Spectrometry of Pull-Down Assay
Three replicates of peptide and control pull-downs were measured to obtain reliable label-free quantitative data. Before injection, samples were reduced, alkylated and digested directly on beads with LysC/Trypsin as previously described (Hubner et al. 2011) . Obtained peptides were separated with a PepMap100 RSLC C18 nano-HPLC column (2, 100, 75 IDx25 , a oViper, Dio e , Ger a o a UltiMate™ RSLC a o system (ThermoFisher Scientific) using a 125 min gradient from 5-60% acetonitrile with 0.1% formic acid and then directly sprayed via a nano-electrospray source (Nanospray Flex Ion Scource, Thermo Scientific) in a Q e pressio of ΔN-β-catenin and the consequent expression of Wnt responsive genes. The endpoint was qRT-PCR of Wnt response biomarkers Axin2, Myc, Ascl2, Tiam1 and the Wnt pathway repressed differentiation marker Car4. Intestinal crypt structures were lysed in 800 µL Trizol (Invitrogen) per 50 µL Matrigel blob of crypt organoids for RNA purification followed by 0.2 mg (per 50 µL Matrigel blob) of the RNA co-precipitant glycogen (Ambion, 5 g• L -1 stock). Chloroform/isoamyl alcohol mixture (Sigma) was added at 20 % Trizol volume to separate organic and aqueous layers and RNA was precipitated from the aqueous layer with 1 volume isopropanol and centrifuged (12,000 g, 20 min) and the pellet washed 2x in 75% ethanol. DNA was re o ed usi g the Tur o DNase kit A io usi g the a ufa turer's i stru tio s. The re erse transcription reaction was carried out using the Improm II kit (Promega) on 700 ng RNA. Analysis with qRT-PCR was carried out using the SensiFAST Sybr Hi-Rox 2x master mix (Bioline) using the manufacturerrecommended cycling protocol. Details of primers used for qRT-PCR can be found in Fehler! Verweisquelle konnte nicht gefunden werden.. Relati e e pressio alues ere al ulated usi g the ΔΔC T method.
Viability Assay
For CellTiter-Glo® Assay, ca. 5,000 cells were plated in 96-well plates (Corning) 24 h prior to assay start. Then, medium was carefully aspirated and cells were treated with fresh pre-warmed complete growth medium supplemented with varying peptide concentrations (0.5-10 µM peptide at a final concentration of 0.5 % DMSO) or DMSO vehicle control only for 72 h. A ordi g to a ufa turer's i stru tio s, plates a d reage ts were equilibrated to room-temperature before one volume of CellTiter-Glo® reagent (Promega) was added to each well. For cell lysis, plates were shaken for 2 min on an orbital shaker. In order to obtain a stable signal, luminescence was recorded 10 min after reagent addition using a microplate reader (Safire2, Tecan).
Wound-Closure Assay
DLD-1 and MCF-7 cells were grown to confluence in 96-ell I ageLo k™ plates Esse Bios ie es i complete gro th ediu . Wou ds ere ge erated ith a Wou dMaker™ de i e reati g a ho oge ous 700-800 µm scratch. Growth medium was then aspirated and cells were then washed twice with PBS, and treated with complete media supplemented with DMSO vehicle control or 10 µM peptides until the scratch wound was closed. Photographs were taken with IncuCyte® Zoom Live-Cell Analysis System (Essen Biosciences). The percentage of wound closure was calculated with IncuCyte® Zoom Software (Essen Biosciences) by measuring the width unoccupied by cells, and normalized to the zero time point. 
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